Cargando…
Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
Autores principales: | Cheng, Xiaojing, Fan, Kelong, Wang, Lin, Ying, Xiangji, Sanders, Andrew J., Guo, Ting, Xing, Xiaofang, Zhou, Meng, Du, Hong, Hu, Ying, Ding, Huirong, Li, Ziyu, Wen, Xianzi, Jiang, Wenguo, Yan, Xiyun, Ji, Jiafu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700721/ https://www.ncbi.nlm.nih.gov/pubmed/36433933 http://dx.doi.org/10.1038/s41419-022-05453-w |
Ejemplares similares
-
TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
por: Cheng, Xiaojing, et al.
Publicado: (2020) -
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
por: Bien-Ly, Nga, et al.
Publicado: (2014) -
Evaluation of ferritin and TfR level in plasma neural-derived exosomes as potential markers of Parkinson’s disease
por: Chen, Zhi-ting, et al.
Publicado: (2023) -
Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway
por: Cui, Can, et al.
Publicado: (2019) -
Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
por: Faresjö, Rebecca, et al.
Publicado: (2023)